Accueil   Diary - News   All news EDAP TMS announces Installation of First Focal One HIFU device in South Korea

EDAP TMS announces Installation of First Focal One HIFU device in South Korea





LYON, France, September 20, 2018 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the installation of the first Focal One device in South Korea, at the renowned Seoul National University Bundang Hospital ("SNUBH").


Dr. Hakmin Lee, Urologist in SNUBH commented: "We are very happy to adopt the first "Focal One" device in our institution and we also believe that Korean patients will significantly benefit from the upcoming HIFU procedures. From our initial experiences, the Focal One device showed extraordinary performance which was definitely beyond our expectations. We are very excited to provide the new technology to Korean patients using our new device."

Jean-François Bachelard, Asia Business Unit Director commented: "We are delighted to start the first Focal One treatments in Seoul National University Hospital, one of the biggest Urology centers in Korea. This prominent clinical site is set to become our HIFU reference center in South Korea to promote prostate cancer treatment using our HIFU technology."


Marc Oczachowski, Chief Executive Officer of EDAP TMS, concluded: "We are thrilled to have the first Korean Focal One installation in such a renowned center of excellence as the Seoul National University Bundang Hospital. After Korean FDA clearance of Focal One in 2016, this installation and first cases performed successfully are a clear and strong milestone in the EDAP HIFU expansion program in South Korea, one of the most important medical device markets in Asia. We look forward to continuing HIFU development with our EDAP local team in South Korea as well as in key Asian markets, where we already benefit from a strong and established position with our ESWL technologies".

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to More details are available by clicking here I agree